Walgreens $100M Settlement: Could You Be Owed Money? Find Out Now
Walgreens has proposed a $100 million settlement to resolve a class-action lawsuit alleging overcharges on generic prescription drugs for insured customers. While Walgreens denies any wrongdoing, the settlement provides compensation to affected customers who meet specific criteria.
Allegations and Settlement Background
The lawsuit accused Walgreens of charging insured customers higher prices for generic drugs compared to those enrolled in the Prescription Savings Club (PSC), a program designed to offer discounts on prescriptions. PSC members paid a $20 annual fee to access reduced prices on thousands of generic drugs, with automatic substitutions for brand-name medications when generics were available.
The program was terminated on August 31, 2024, but the allegations of unequal pricing lingered. Walgreens stated, โWe admit no liability and believe these claims never had any merit. The Prescription Savings Club was launched over 15 years ago to provide equitable access to lower-cost medications for uninsured and underinsured individuals.โ The settlement, they said, allows the company to focus on broader strategic goals.
Who Qualifies for Compensation?
Customers may be eligible for compensation if they meet the following criteria:
- Purchased one or more prescription drugs at Walgreens.
- Used insurance benefits to pay for those prescriptions.
- Made these purchases between January 1, 2007, and November 18, 2024.
The settlement applies to insured customers who may have been charged more for generic drugs compared to PSC members.
Claim Details and Next Steps
Eligible customers must file their claims by April 17, 2025, through the official settlement website: savingsclubsettlement.com. Notifications have been sent to customers via email from [email protected].
The amount of compensation will depend on:
- How much the customer paid for prescription drugs during the eligibility period.
- The total number of valid claims submitted.
Payment Timeline
A court hearing to finalize the settlement is scheduled for September 10, 2025. Payments to eligible claimants will be distributed after the settlement is approved. For more information, customers are encouraged to visit the official settlement website. This settlement highlights the importance of transparency in healthcare pricing and ensures that affected customers receive fair compensation for any discrepancies in prescription drug costs. Whether or not Walgreens admits liability, the resolution underscores its commitment to addressing customer concerns while turning its focus toward future strategies.
Comments are closed, but trackbacks and pingbacks are open.